Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/1/569
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKirmani Nen_US
dc.contributor.authorHaq Ten_US
dc.date.accessioned2017-01-30T08:16:12Z-
dc.date.available2017-01-30T08:16:12Z-
dc.identifier.urihttp://hdl.handle.net/123456789/175806-
dc.identifier.urihttp://localhost:8080/xmlui/handle/1/569-
dc.description.abstractThe broad objective of this case is to bring out the cost and benefits of multinational companies and foreign direct investment. This would include the global effects of multinationals, their benefits to the home country, home host company conflicts and views of the host country.en_US
dc.publisherNOen_US
dc.subjectPharmaceuticals-
dc.subject.classificationBusiness,Government,International Economyen_US
dc.subject.otherCost/benefit analysisen_US
dc.subject.otherforeign investmenten_US
dc.subject.othermultinationalen_US
dc.titlePHARMACEUTICAL INDUSTRY IN PAKISTAN: ROLE OF GLAXO- A MULTINATIONALCOMPANYen_US
dc.type16-158-88-1en_US
dc.locationcase research centreen_US
Appears in Collections:Business Case Studies

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.